stocks logo

NMTC

NeuroOne Medical Technologies Corp
$
0.887
-0.015(-1.664%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.920
Open
0.905
VWAP
--
Vol
355.14K
Mkt Cap
44.17M
Low
0.8106
Amount
--
EV/EBITDA(TTM)
--
Total Shares
27.84M
EV
44.21M
EV/OCF(TTM)
--
P/S(TTM)
3.02
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Show More
1 Analyst Rating
up Image
63.55% Upside
Wall Street analysts forecast NMTC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NMTC is 1.45 USD with a low forecast of 1.45 USD and a high forecast of 1.45  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
up Image
63.55% Upside
Current: 0.887
sliders
Low
1.45
Averages
1.45
High
1.45
No Data

Valuation Metrics

The current forward P/E ratio for NeuroOne Medical Technologies Corp (NMTC.O) is -4.93, compared to its 5-year average forward P/E of -3.15. For a more detailed relative valuation and DCF analysis to assess NeuroOne Medical Technologies Corp 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.15
Current PE
-4.93
Overvalued PE
-1.34
Undervalued PE
-4.96

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.88
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.04
Undervalued EV/EBITDA
-1.79

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
104.14
Current PS
4.90
Overvalued PS
328.43
Undervalued PS
-120.15

Financials

Annual
Quarterly
FY2025Q2
YoY :
+0.67%
1.39M
Total Revenue
FY2025Q2
YoY :
-7.14%
-2.68M
Operating Profit
FY2025Q2
YoY :
-20.47%
-2.27M
Net Income after Tax
FY2025Q2
YoY :
-36.36%
-0.07
EPS - Diluted
FY2025Q2
YoY :
-96.99%
-66.41K
Free Cash Flow
FY2025Q2
YoY :
+96.16%
55.61
Gross Profit Margin - %
FY2025Q2
YoY :
-81.32%
-59.97
FCF Margin - %
FY2025Q2
YoY :
-21.00%
-163.76
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
12.9K
USD
4
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
2
150.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

NMTC News & Events

Events Timeline

2025-07-23 (ET)
2025-07-23
08:41:36
NeuroOne Medical receives notice of allowance for key patent from USPTO
select
2025-06-23 (ET)
2025-06-23
08:45:14
NeuroOne Medical reports patient surpasses one year milestone of seizure freedom
select
2025-06-03 (ET)
2025-06-03
08:38:08
NeuroOne Medical appoints Johns as General Counsel, Corporate Secretary
select
Sign Up For More Events

News

9.0
06-23NASDAQ.COM
NeuroOne Medical Technologies Reports Successful Seizure-Free Milestone in First Patient Treated with OneRF® Ablation System
5.0
06-03Newsfilter
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
1.0
05-29Newsfilter
NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025
Sign Up For More News

FAQ

arrow icon

What is NeuroOne Medical Technologies Corp (NMTC) stock price today?

The current price of NMTC is 0.8866 USD — it has decreased -1.66 % in the last trading day.

arrow icon

What is NeuroOne Medical Technologies Corp (NMTC)'s business?

arrow icon

What is the price predicton of NMTC Stock?

arrow icon

What is NeuroOne Medical Technologies Corp (NMTC)'s revenue for the last quarter?

arrow icon

What is NeuroOne Medical Technologies Corp (NMTC)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for NeuroOne Medical Technologies Corp (NMTC)'s fundamentals?

arrow icon

How many employees does NeuroOne Medical Technologies Corp (NMTC). have?

arrow icon

What is NeuroOne Medical Technologies Corp (NMTC) market cap?